Clinical trials for

Resectable Hepatocellular Carcinoma With High Risk Of Recurrence

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +3 moreCheck eligibility →

RecruitingPost-approval study

Zhengzhou, Henan, ChinaCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingSafety & dosing

Fuzhou, Fujian, China +2 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +3 moreCheck eligibility →

RecruitingPost-approval study

Zhengzhou, Henan, ChinaCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingSafety & dosing

Fuzhou, Fujian, China +2 moreCheck eligibility →

4 trials · Recruiting

4

Trials actively recruiting patients for Resectable Hepatocellular Carcinoma With High Risk Of Recurrence

Trial status

Phase

Location